Skip to main content

Fiscal Wizard · Single-issue tearsheet

FMS / Jun 21, 2026 Run #7274

FMS

Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Composite verdict

A 76.1 / 100
Bullish setup · Trend Following 11 drivers · 3 gates blocking
  • Rate of Change
  • TRIX Zero-Line
  • Keltner Channels
Consider long call target Δ ~0.70 · ~35 DTE Bullish setup, Grade A → ITM call target

Industry rank 3rd of 53 in Medical Care Facilities

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 14 signals0% Bear
Momentum Bullish 99Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety +26%
Asset value $24.78Earnings power value $12.62Price $23.59

The discount is mostly unpriced earnings power: price ($23.59) sits between asset value ($24.78) and no-growth earnings power value ($12.62).

Fundamentals Mixed

52.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Free Cash Flow Yield 100
OCF to Net Income 0
Margin of Safety 94
Cash Conversion 0
Dividend Yield 84
Cash Conversion Cycle 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Rate of Change, TRIX Zero-Line, Keltner Channels); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Rate of Change 87
Vortex Signal 85
TRIX Zero-Line 83

Risk Gates

3 blocking 5 caution

3 guards active, 27 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for FMS.